Results 171 to 180 of about 75,125 (295)
OCT4-induced oligodendrocyte progenitor cells promote remyelination and ameliorate disease [PDF]
Wonjin Yun +17 more
openalex +1 more source
Breast cancer cell‐derived stem cell factor (SCF) activates c‐KIT‐mediated MAPK/ERK signaling in mast cells, inducing IFNB1 production. Mast cell‐derived IFNB1 then engages the IFNAR1‐STAT1 axis in breast cancer cells, activating the Type I interferon pathway to promote tumor stemness and progression.
Siqin Li +16 more
wiley +1 more source
Enhanced proliferation and differentiation of Oct4- and Sox2-overexpressing human adipose tissue mesenchymal stem cells [PDF]
Sei‐Myoung Han +7 more
openalex +1 more source
CD44‐targeted CNPs co‐deliver Zn2+ and MIT–ALA to CRC cells. Intracellularly, Zn2+ inhibits GLUT1‐dependent glycolysis, and ALA disrupts mitochondrial function, driving metabolic exhaustion in CSCs. This mitochondrial damage primes GSDMD‐mediated pyroptosis, accompanied by the release of pro‐inflammatory cytokines (IL‑1β, IL‑18).
Qinxia Chang +8 more
wiley +1 more source
ABSTRACT Skin boosters are increasingly used to improve dermal quality through injectable and device‐assisted approaches; however, definitions and clinical evidence remain heterogeneous. Aims To provide an updated overview and propose a practical classification of skin boosters, including mechanisms, delivery methods, clinical outcomes, and limitations.
Kyu‐ho Yi +7 more
wiley +1 more source
Oct4, a novel marker for human gastric cancer [PDF]
Zhong Chen +10 more
openalex +1 more source
Direct activation of human and mouse Oct4 genes using engineered TALE and Cas9 transcription factors [PDF]
Jiabiao Hu +14 more
openalex +1 more source
Perivascular cell-specific knockout of the stem cell pluripotency gene Oct4 inhibits angiogenesis [PDF]
Daniel L. Hess +8 more
openalex +1 more source
PRX5 as a critical driver of colorectal cancer stemness and tumorigenicity. [PDF]
Lee SW +8 more
europepmc +1 more source

